104 related articles for article (PubMed ID: 27982417)
21. Axitinib effectively inhibits BCR-ABL1(T315I) with a distinct binding conformation.
Pemovska T; Johnson E; Kontro M; Repasky GA; Chen J; Wells P; Cronin CN; McTigue M; Kallioniemi O; Porkka K; Murray BW; Wennerberg K
Nature; 2015 Mar; 519(7541):102-5. PubMed ID: 25686603
[TBL] [Abstract][Full Text] [Related]
22. Synthetic small interfering RNAs reduce bcr-abl gene expression in leukaemic cells of de novo Philadelphia(+) acute myeloid leukaemia.
Koldehoff M; Steckel NK; Beelen DW; Elmaagacli AH
Clin Exp Med; 2006 Mar; 6(1):45-7. PubMed ID: 16550344
[No Abstract] [Full Text] [Related]
23. Multiple erythrophagocytosis by erythroid blasts in acute myeloid leukemia with BCR-ABL1.
Mellado-Gázquez Á; Gómez-Núñez MR; Jurado-Herrera S; Prats-Martín C; Caballero-Velázquez T; Morales-Camacho RM
Ann Hematol; 2022 Jun; 101(6):1375-1377. PubMed ID: 35083526
[No Abstract] [Full Text] [Related]
24. Variant e19a2 BCR-ABL1 fusion transcript in typical chronic myeloid leukemia.
Tutulan-Cunita AC; Chirieac SM; Mocanu G; Luca C; Costache M; Lungeanu A; Arghir A
Clin Lab; 2011; 57(9-10):785-8. PubMed ID: 22029197
[TBL] [Abstract][Full Text] [Related]
25. Erythrophagocytosis by blasts in acute myeloid leukaemia harbouring the BCR-ABL1 fusion gene.
Murayama H; Matsushita H; Obayashi Y; Ando K
Br J Haematol; 2014 Dec; 167(5):586. PubMed ID: 25256906
[No Abstract] [Full Text] [Related]
26. Extramedullary BCR-ABL1-negative myeloid leukemia in a patient with chronic myeloid leukemia and synchronous cytogenetic abnormalities in Philadelphia-positive and -negative clones during imatinib therapy.
Quintás-Cardama A; Kantarjian H; Abruzzo LV; Cortes J
Leukemia; 2007 Nov; 21(11):2394-6. PubMed ID: 17690707
[No Abstract] [Full Text] [Related]
27. Chronic Myeloid Leukemia With Rare Variant b2a3 (e13a3) BCR-ABL1 Fusion.
Ha J; Cheong JW; Shin S; Lee ST; Choi JR
Ann Lab Med; 2016 May; 36(3):287-9. PubMed ID: 26915625
[No Abstract] [Full Text] [Related]
28. Significance of
Ghosh S; Roth J; Babushok D; Lim M
Leuk Lymphoma; 2022 Aug; 63(8):1975-1979. PubMed ID: 35290157
[No Abstract] [Full Text] [Related]
29. High frequency of BTG1 deletions in patients with BCR-ABL1-positive acute leukemia.
Xie J; Wang Q; Wang Q; Yao H; Wen L; Ma L; Wu D; Chen S
Cancer Genet; 2014 May; 207(5):226-30. PubMed ID: 24998463
[TBL] [Abstract][Full Text] [Related]
30. Acute lymphoblastic leukaemia with an e1a3 BCR-ABL1 fusion.
Langabeer SE; Haslam K; Kelly J; Leahy M; Vandenberghe E
Acta Haematol; 2011; 126(4):214-5. PubMed ID: 21934295
[No Abstract] [Full Text] [Related]
31. Detection of BCR-ABL1 kinase domain mutations causing imatinib resistance in chronic myelogenous leukemia.
Moore FR; Yang F; Press RD
Methods Mol Biol; 2013; 999():25-39. PubMed ID: 23666688
[TBL] [Abstract][Full Text] [Related]
32. Fine structure of translocation breakpoints within the major breakpoint region in BCR-ABL1-positive leukemias.
Burmeister T; Gröger D; Kühn A; Hoelzer D; Thiel E; Reinhardt R
DNA Repair (Amst); 2011 Nov; 10(11):1131-7. PubMed ID: 21944569
[TBL] [Abstract][Full Text] [Related]
33. Characterization of a novel variant BCR-ABL1 fusion transcript in a patient with chronic myeloid leukemia: Implications for molecular monitoring.
Crampe M; Haslam K; Kelly J; Conneally E; Langabeer SE
Hematol Oncol Stem Cell Ther; 2017 Jun; 10(2):85-88. PubMed ID: 27013275
[TBL] [Abstract][Full Text] [Related]
34. The Philadelphia chromosome in leukemogenesis.
Kang ZJ; Liu YF; Xu LZ; Long ZJ; Huang D; Yang Y; Liu B; Feng JX; Pan YJ; Yan JS; Liu Q
Chin J Cancer; 2016 May; 35():48. PubMed ID: 27233483
[TBL] [Abstract][Full Text] [Related]
35. Abnormal chromatin clumping in granulocytes in a case of Ph1-negative, BCR-ABL rearrangement positive, haematologically atypical chronic myeloid leukaemia (CML).
Tertian G; Misrahi M; Diallo D; Mielot F; Leonard C; Salmeron S; Tchernia G
Nouv Rev Fr Hematol (1978); 1995; 37(4):245-7. PubMed ID: 8904205
[TBL] [Abstract][Full Text] [Related]
36. Measurement of BCR-ABL1 by RT-qPCR in chronic myeloid leukaemia: findings from an International EQA Programme.
Scott S; Travis D; Whitby L; Bainbridge J; Cross NCP; Barnett D
Br J Haematol; 2017 May; 177(3):414-422. PubMed ID: 28295199
[TBL] [Abstract][Full Text] [Related]
37. Mixed phenotype acute leukaemia with t(9,22), BCR-ABL1: A case report.
Yong WL; Yusof N; Ithnin A; Shuib S; Tumian R; Yousuf R; Abdul Aziz S
Malays J Pathol; 2020 Dec; 42(3):469-476. PubMed ID: 33361731
[TBL] [Abstract][Full Text] [Related]
38. Late-appearing Philadelphia chromosome in childhood acute myeloid leukemia.
Shah N; Leaker MT; Teshima I; Baruchel S; Abdelhaleem M; Ye CC
Pediatr Blood Cancer; 2008 May; 50(5):1052-3. PubMed ID: 18213712
[TBL] [Abstract][Full Text] [Related]
39. Peripheral blood vs. bone marrow for molecular monitoring of BCR-ABL1 levels in chronic myelogenous leukemia, a retrospective analysis in allogeneic bone marrow recipients.
Ballestrero A; Cirmena G; Dominietto A; Garuti A; Rocco I; Cea M; Moran E; Nencioni A; Miglino M; Raiola AM; Bacigalupo A; Patrone F
Int J Lab Hematol; 2010 Aug; 32(4):387-91. PubMed ID: 19968720
[TBL] [Abstract][Full Text] [Related]
40. A rare, in-frame BCR-ABL fusion (e13a3) in a patient with an aggressive chronic myeloid leukaemia.
Otazú IB; Belén Rivero M; Olício R; Pinto A; Zalcberg I; Seuánez HN
Acta Haematol; 2002; 108(3):150-3. PubMed ID: 12373087
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
